


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-7.77%
+4.62%
-3.25%
-3.25%
+9.71%
EXAS
Exact Sciences
$67.75
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Chart
$59.36 (+14.13%)
$45.6 (+48.57%)
$52.34 (+29.44%)
$53.07 (+27.66%)
EXAS has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

EXAS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
EXAS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
EXAS Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is EXAS current stock price?
What are EXAS stock strengths?
What risks are associated with EXAS stock?
When is EXAS next earnings report?
What is EXAS market cap and volume?
What is EXAS's current Stock IQ?
Should I buy EXAS stock right now?
Is EXAS a Strong Buy right now?
What does a 'Strong Buy' rating mean for EXAS?
What does a 'Strong Sell' rating mean for EXAS?
What factors influence EXAS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.77%
+4.62%
-3.25%
-3.25%
+9.71%
EXAS
Exact Sciences
Current Price
$67.75
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Chart
$59.36 (+14.13%)
$45.6 (+48.57%)
$52.34 (+29.44%)
$53.07 (+27.66%)
EXAS Analysts Opinion
EXAS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
EXAS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
EXAS Street Sentiment is extremely bullish and have positive views on the near-term outlook
EXAS has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
EXAS Latest Analysis
Piper Sandler Maintains Exact Sciences (EXAS) Overweight Recommendation. Fintel reports that on November 11 2025 Piper Sandler maintained coverage of Exact Sciences (NasdaqCM:EXAS) with a Overweight recommendation. Analyst Price Forecast Suggests 5.51% Upside
Wed Nov 12, 2025
Wells Fargo Maintains Exact Sciences (EXAS) Overweight Recommendation. Fintel reports that on November 5 2025 Wells Fargo maintained coverage of Exact Sciences (NasdaqCM:EXAS) with a Overweight recommendation. Analyst Price Forecast Suggests 2.27% Upside
Thu Nov 6, 2025
Earnings Estimates Rising for Exact Sciences (EXAS): Will It Gain?. Exact Sciences (EXAS) shares have started gaining and might continue moving higher in the near term as indicated by solid earnings estimate revisions.
Wed Nov 5, 2025
Guggenheim Maintains Exact Sciences (EXAS) Buy Recommendation. Fintel reports that on November 4 2025 Guggenheim maintained coverage of Exact Sciences (NasdaqCM:EXAS) with a Buy recommendation. Analyst Price Forecast Suggests 2.37% Upside
Wed Nov 5, 2025
Benchmark Maintains Exact Sciences (EXAS) Buy Recommendation. Fintel reports that on November 4 2025 Benchmark maintained coverage of Exact Sciences (NasdaqCM:EXAS) with a Buy recommendation. Analyst Price Forecast Suggests 2.37% Upside
Wed Nov 5, 2025
Baird Maintains Exact Sciences (EXAS) Outperform Recommendation. Fintel reports that on November 4 2025 Baird maintained coverage of Exact Sciences (NasdaqCM:EXAS) with a Outperform recommendation. Analyst Price Forecast Suggests 2.37% Upside
Wed Nov 5, 2025
TD Cowen Maintains Exact Sciences (EXAS) Buy Recommendation. Fintel reports that on November 4 2025 TD Cowen maintained coverage of Exact Sciences (NasdaqCM:EXAS) with a Buy recommendation. Analyst Price Forecast Suggests 2.37% Upside
Wed Nov 5, 2025
Barclays Maintains Exact Sciences (EXAS) Overweight Recommendation. Fintel reports that on November 4 2025 Barclays maintained coverage of Exact Sciences (NasdaqCM:EXAS) with a Overweight recommendation. Analyst Price Forecast Suggests 2.37% Upside
Wed Nov 5, 2025
Stifel Maintains Exact Sciences (EXAS) Buy Recommendation. Fintel reports that on November 4 2025 Stifel maintained coverage of Exact Sciences (NasdaqCM:EXAS) with a Buy recommendation. Analyst Price Forecast Suggests 2.37% Upside
Wed Nov 5, 2025
Exact Sciences (EXAS) is an Intriguing Medical Stock to Watch After Q3 Earnings. Recognized as a leader in medical diagnostics the upside potential for Exact Sciences (EXAS) stock has been lifted by its improved operational and financial performance.
Wed Nov 5, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
EXAS Stock trends
EXAS Stock performance
EXAS Stock analysis
EXAS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.